DarioHealth (DRIO) Cash & Current Investments (2012 - 2026)

DarioHealth (DRIO) has reported Cash & Current Investments for 15 consecutive years, with $14.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Current Investments fell 37.03% year-over-year to $14.0 million; the trailing twelve-month figure through Jun 2026 stood at $14.0 million (down 37.03% YoY), and the FY2025 full-year result was $26.0 million, down 8.59% from the prior year.
• Cash & Current Investments declined to $14.0 million in Q2 2026 per DRIO's latest filing, from $20.0 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $68.1 million in Q2 2022 and bottomed at $14.0 million in Q2 2026.
• Historically, Cash & Current Investments has averaged $36.4 million across 5 years, with a median of $33.7 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments plunged 62.93% in 2024, then jumped 95.79% in 2025.
• Over 5 years, Cash & Current Investments stood at $49.5 million in 2022, then fell by 25.11% to $37.1 million in 2023, then slipped by 23.26% to $28.5 million in 2024, then slipped by 8.59% to $26.0 million in 2025, then plunged by 46.34% to $14.0 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $14.0 million, $20.0 million, and $26.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.